Thrivent Financial for Lutherans’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $4.95M | Sell |
|
|||||
|
2024
Q3 | $11.7M | Buy |
|
|||||
|
2024
Q2 | $10.7M | Sell |
|
|||||
|
2024
Q1 | $17.3M | Buy |
|
|||||
|
2023
Q4 | $14.3M | Sell |
|
|||||
|
2023
Q3 | $10.8M | Buy |
|
|||||
|
2023
Q2 | $10.2M | Sell |
|
|||||
|
2023
Q1 | $13.6M | Buy |
|
|||||
|
2022
Q4 | $15.3M | Buy |
|
|||||
|
2022
Q3 | $12.7M | Sell |
|
|||||
|
2022
Q2 | $12.6M | Sell |
|
|||||
|
2022
Q1 | $17.2M | Sell |
|
|||||
|
2021
Q4 | $20.1M | Sell |
|
|||||
|
2021
Q3 | $24.6M | Sell |
|
|||||
|
2021
Q2 | $23.6M | Buy |
|
|||||
|
2021
Q1 | $21.4M | Buy |
|